SCHEMBL767424

SCHEMBL767424

CO[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PYGB P11216 1/20 0.43
LGALS8 O00214 3/20 0.41
LGALS1 P09382 2/20 0.41
LGALS3 P17931 2/20 0.41
LGALS9 O00182 1/20 0.41
MAPK1 P28482 1/20 0.40
OGA O60502 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SLC2A1 P11166 1/20 0.38
FGF1 P05230 1/20 0.38
SLC5A2 P31639 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18390837 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL78631 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL6157450 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL767465 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL13446418 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL14479870 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL3269920 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL505006 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL1985946 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9
SCHEMBL248110 1.00 PYGB (0.43) PYGBLGALS8LGALS1LGALS3LGALS9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238216-A1 SLOW-RELEASE FORMULATION GLYCOSCIENCE, S.L. (ES) 2024-07-18 US claimed
EP-4344398-A1 SLOW-RELEASE FORMULATION Glycoscience, S.L. (ES) 2024-04-03 EP claimed
WO-2023099327-A1 SLOW-RELEASE FORMULATION GLYCOSCIENCE, S.L. (ES) 2023-06-08 WO claimed
CN-113121620-B Method for synthesizing uronic acid by catalytic oxidation of pyranoside 河北科技大学 2022-07-22 CN claimed
CN-109663575-B Special rare earth metal La-MOFs adsorption material for alpha-pinene targeted intelligent adsorption and preparation method thereof 内蒙古农业大学 2021-10-26 CN claimed
CN-109759020-B Nd-MOFs gas adsorption material and preparation method and application thereof 内蒙古农业大学 2021-10-01 CN claimed
CN-109967038-B Ce-MOFs material for adsorbing VOCs released in wood drying process and use method 内蒙古农业大学 2021-10-01 CN claimed
CN-113121620-A Method for synthesizing uronic acid by catalytic oxidation of pyranoside 河北科技大学 2021-07-16 CN claimed
CN-105153251-A Benzylation method for monosaccharide glucoside ZHEJIANG DEYER CHEMICALS CO LTD 2015-12-16 CN claimed
CN-103665061-B A kind of synthetic method of regioselectivity acetylize methyl D-pyranoside NORTHWEST A & F UNIVERSITY (CN) 2015-11-04 CN claimed
WO-2015011266-A1 METHOD FOR PRODUCING EXOPOLYSACCHARIDES, PRODUCTS AND USES THEREOF Technische Universität München (DE) 2015-01-29 WO claimed
EP-2829612-A1 Method for producing exopolysaccharides, products and uses thereof Technische Universität München (DE) 2015-01-28 EP claimed
CN-103665061-A Synthetic method for regioselectively-acetylated methyl-D-pyranosides UNIV NORTHWEST A&F 2014-03-26 CN claimed
CN-1286725-A Vitrification quality guarantee method for sensitive biological sample UNIVERSAL PRESERVATION TECHNOLOGIES INC (US) 2001-03-07 CN claimed
EP-0598051-B1 ENZYMATIC METHOD FOR SYNTHESIS OF CARBOHYDRATES PROCUR AB (SE) 1999-03-17 EP claimed
CN-118434282-A Sustained release preparation 格莱克科学有限公司 2024-08-02 CN disclosed
US-20240238216-A1 SLOW-RELEASE FORMULATION GLYCOSCIENCE, S.L. (ES) 2024-07-18 US disclosed
EP-0277139-B1 7-AMINO-4-METHYL-COUMARIN-3-CARBOXYALKYL DERIVATIVES AND FLUORESCENT CONJUGATES THEREOF BIOCARB AB (SE) 1990-08-08 EP disclosed
EP-0369182-A1 Antitumour saccharide conjugates Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 1990-05-23 EP disclosed
WO-1990004597-A1 TUMOR-INHIBITING SACCHARIDE CONJUGATES Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 1990-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238216-A1 SLOW-RELEASE FORMULATION SORD, G6PD, GMDS PYGB 2094/4885LGALS8 1114/4885LGALS1 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.